© Reuters. FILE PHOTO: A bottle of Zantac heartburn drug is seen in this picture illustration taken October 1, 2019. REUTERS/Brendan McDermid/Illustration
(Reuters) – Drugmakers GSK Plc, Pfizer Inc (NYSE:), Sanofi (NASDAQ:) SA and Boehringer Ingelheim on Tuesday defeated thousands of lawsuits in U.S. federal court claiming that the heartburn drug Zantac caused cancer, as a judge found the claims were not backed by sound science.
While the companies, which have all marketed the drug at different times, still face tens of thousands of similar lawsuits in state courts, the ruling by U.S. District Judge Robin Rosenberg in West Palm Beach, Florida, knocks out a significant portion of their potential liability.
Be the first to comment